Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yating Sun

1PUBLICATIONS

17CO-AUTHORS

Tumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 18, 2024

Inhibition of JNK Signaling Overcomes Cancer-Associated Fibroblast-Mediated Immunosuppression and Enhances the Efficacy of Immunotherapy in Bladder Cancer.

Chengying Cui, Haojie Zhang, Congcong Yang

Pageof 1

Frequent Collaborators

1 joint publications

Chengying Cui

1 joint publications

Haojie Zhang

1 joint publications

Congcong Yang

1 joint publications

Mingwei Yin

1 joint publications

Xinkun Teng

1 joint publications

Miaomiao Yang

1 joint publications

Dejie Kong

1 joint publications

Jinzhi Zhang

1 joint publications

Weidong Peng

1 joint publications

Zhimin Chu

Frequent Collaborators

1 joint publications

Chengying Cui

1 joint publications

Haojie Zhang

1 joint publications

Congcong Yang

1 joint publications

Mingwei Yin

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos